CoChat

Computational approaches for predicting variant impact: An overview from resources, principles to applications

Open access
Liu, Ye, Yeung, William S. B., Chiu, Philip C. N., Cao, Dandan · 2022 · Frontiers in Genetics
Cited by 41

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

One objective of human genetics is to unveil the variants that contribute to human diseases. With the rapid development and wide use of next-generation sequencing (NGS), massive genomic sequence data have been created, making personal genetic information available. Conventional experimental evidence is critical in establishing the relationship between sequence variants and phenotype but with low efficiency. Due to the lack of comprehensive databases and resources which present clinical and experimental evidence on genotype-phenotype relationship, as well as accumulating variants found from NGS, different computational tools that can predict the impact of the variants on phenotype have been greatly developed to bridge the gap. In this review, we present a brief introduction and discussion about the computational approaches for variant impact prediction. Following an innovative manner, we mainly focus on approaches for non-synonymous variants (nsSNVs) impact prediction and categorize them into six classes. Their underlying rationale and constraints, together with the concerns and remedies raised from comparative studies are discussed. We also present how the predictive approaches employed in different research. Although diverse constraints exist, the computational predictive approaches are indispensable in exploring genotype-phenotype relationship.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fgene.2022.981005

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 210

  1. Accetturo, 2020, In-silico analysis of NF1 missense variants in ClinVar: Translating variant predictions into variant interpretation and classification, Int. J. Mol. Sci., 21, E721, 10.3390/ijms21030721 · DOI
  2. Adhikari, 2019, Gene-specific features enhance interpretation of mutational impact on acid alpha-glucosidase enzyme activity, Hum. Mutat., 40, 1507, 10.1002/humu.23846 · DOI
  3. Adzhubei, 2010, A method and server for predicting damaging missense mutations, Nat. Methods, 7, 248, 10.1038/nmeth0410-248 · DOI · Paper page
  4. Ahmed, 2015, A structure-based approach to predict predisposition to amyloidosis, Alzheimers Dement., 11, 681, 10.1016/j.jalz.2014.06.007 · DOI · Paper page
  5. Ainscough, 2016, DoCM: A database of curated mutations in cancer, Nat. Methods, 13, 806, 10.1038/nmeth.4000 · DOI · Paper page
  6. Aleman, 2014, A web-based interactive framework to assist in the prioritization of disease candidate genes in whole-exome sequencing studies, Nucleic Acids Res., 42, W88, 10.1093/nar/gku407 · DOI
  7. Alirezaie, 2018, ClinPred: Prediction tool to identify disease-relevant nonsynonymous single-nucleotide variants, Am. J. Hum. Genet., 103, 474, 10.1016/j.ajhg.2018.08.005 · DOI · Paper page
  8. Altschul, 1990, Basic local alignment search tool, J. Mol. Biol., 215, 403, 10.1016/S0022-2836(05)80360-2 · doi:10.1016/s0022-2836(05)80360-2 · Paper page
  9. Amberger, 2019, OMIM.org: Leveraging knowledge across phenotype-gene relationships, Nucleic Acids Res., 47, D1038-D1043, 10.1093/nar/gky1151 · DOI · Paper page
  10. Anderson, 2022, An expanded phenotype centric benchmark of variant prioritisation tools, Hum. Mutat., 43, 539, 10.1002/humu.24362 · DOI
  11. Andreoletti, 2019, Reports from the fifth edition of CAGI: The critical assessment of genome interpretation, Hum. Mutat., 40, 1197, 10.1002/humu.23876 · DOI · Paper page
  12. Ashburner, 2000, Gene ontology: Tool for the unification of biology. The gene ontology consortium, Nat. Genet., 25, 25, 10.1038/75556 · DOI · Paper page
  13. Ayme, 1998, Information on rare diseases: The Orphanet project, La Rev. Med. Interne, 19, 376S, 10.1016/s0248-8663(98)90021-2 · doi:10.1016/s0248-8663(98)90021-2
  14. Azaiez, 2018, Genomic landscape and mutational Signatures of deafness-associated genes, Am. J. Hum. Genet., 103, 484, 10.1016/j.ajhg.2018.08.006 · DOI · Paper page
  15. Baker, 2000, The EMBL nucleotide sequence database, Nucleic Acids Res., 28, 19, 10.1093/nar/28.1.19 · DOI · Paper page
  16. Banck, 2021, Comparison of open-access databases for clinical variant interpretation in cancer: A case study of MDS/AML, Cancer Genomics Proteomics, 18, 157, 10.21873/cgp.20250 · DOI
  17. Banerjee, 2021, Sequence neighborhoods enable reliable prediction of pathogenic mutations in cancer genomes, Cancers (Basel), 13, 2366, 10.3390/cancers13102366 · DOI
  18. Bayman, 2021, Multicollinearity in logistic regression models, Anesth. Analg., 133, 362, 10.1213/ANE.0000000000005593 · doi:10.1213/ane.0000000000005593
  19. Bendl, 2014, PredictSNP: Robust and accurate consensus classifier for prediction of disease-related mutations, PLoS Comput. Biol., 10, e1003440, 10.1371/journal.pcbi.1003440 · DOI · Paper page
  20. Berliner, 2014, Combining structural modeling with ensemble machine learning to accurately predict protein fold stability and binding affinity effects upon mutation, PLoS One, 9, e107353, 10.1371/journal.pone.0107353 · DOI · Paper page
  21. Berman, 2000, The protein Data Bank, Nucleic Acids Res., 28, 235, 10.1093/nar/28.1.235 · DOI · Paper page
  22. Blue, 2014, Targeted next-generation sequencing identifies pathogenic variants in familial congenital heart disease, J. Am. Coll. Cardiol., 64, 2498, 10.1016/j.jacc.2014.09.048 · DOI
  23. Bonaventura, 1968, Hemoglobin Kansas, a human hemoglobin with a neutral amino acid substitution and an abnormal oxygen equilibrium, J. Biol. Chem., 243, 980, 10.1016/s0021-9258(18)93612-4 · DOI · Paper page
  24. Boucher, 2016, Quantifying and understanding the fitness effects of protein mutations: Laboratory versus nature, Protein Sci., 25, 1219, 10.1002/pro.2928 · DOI · Paper page
  25. Brock, 2008, Which missing value imputation method to use in expression profiles: A comparative study and two selection schemes, BMC Bioinforma., 9, 12, 10.1186/1471-2105-9-12 · DOI · Paper page
  26. Bromberg, 2007, Snap: Predict effect of non-synonymous polymorphisms on function, Nucleic Acids Res., 35, 3823, 10.1093/nar/gkm238 · DOI · Paper page
  27. Brookes, 2015, Human genotype-phenotype databases: Aims, challenges and opportunities, Nat. Rev. Genet., 16, 702, 10.1038/nrg3932 · DOI
  28. Bu, 2022, DVPred: A disease-specific prediction tool for variant pathogenicity classification for hearing loss, Hum. Genet., 141, 401, 10.1007/s00439-022-02440-1 · DOI
  29. Calabrese, 2009, Functional annotations improve the predictive score of human disease-related mutations in proteins, Hum. Mutat., 30, 1237, 10.1002/humu.21047 · DOI · Paper page
  30. Callaway, 2022, What's next for AlphaFold and the AI protein-folding revolution, Nature, 604, 234, 10.1038/d41586-022-00997-5 · DOI · Paper page
  31. Canson, 2020, Variant effect on splicing regulatory elements, branchpoint usage, and pseudoexonization: Strategies to enhance bioinformatic prediction using hereditary cancer genes as exemplars, Hum. Mutat., 41, 1705, 10.1002/humu.24074 · DOI
  32. Capriotti, 2013, Collective judgment predicts disease-associated single nucleotide variants, BMC Genomics, 14, S2, 10.1186/1471-2164-14-S3-S2 · DOI · Paper page
  33. Capriotti, 2006, Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information, Bioinformatics, 22, 2729, 10.1093/bioinformatics/btl423 · DOI · Paper page
  34. Carter, 2013, Identifying Mendelian disease genes with the variant effect scoring tool, BMC Genomics, 14, S3, 10.1186/1471-2164-14-S3-S3 · DOI · Paper page
  35. Chennen, 2020, Mistic: A prediction tool to reveal disease-relevant deleterious missense variants, PLoS One, 15, e0236962, 10.1371/journal.pone.0236962 · DOI · Paper page
  36. Choi, 2015, PROVEAN web server: A tool to predict the functional effect of amino acid substitutions and indels, Bioinformatics, 31, 2745, 10.1093/bioinformatics/btv195 · DOI · Paper page
  37. Chun, 2009, Identification of deleterious mutations within three human genomes, Genome Res., 19, 1553, 10.1101/gr.092619.109 · DOI · Paper page
  38. Cingolani, 2012, A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3, Fly. (Austin), 6, 80, 10.4161/fly.19695 · DOI · Paper page
  39. Ciriello, 2015, Comprehensive molecular portraits of invasive lobular breast cancer, Cell., 163, 506, 10.1016/j.cell.2015.09.033 · DOI · Paper page
  40. Cooper, 2011, Needles in stacks of needles: Finding disease-causal variants in a wealth of genomic data, Nat. Rev. Genet., 12, 628, 10.1038/nrg3046 · DOI · Paper page
  41. Cornish, 2018, PhenoRank: Reducing study bias in gene prioritization through simulation, Bioinformatics, 34, 2087, 10.1093/bioinformatics/bty028 · DOI · Paper page
  42. Coutant, 2012, Eva: Exome Variation Analyzer, an efficient and versatile tool for filtering strategies in medical genomics, BMC Bioinforma., 13, S9, 10.1186/1471-2105-13-S14-S9 · DOI
  43. Cubuk, 2021, Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes, Genet. Med., 23, 2096, 10.1038/s41436-021-01265-z · DOI · Paper page
  44. Cunningham, 2015, Improving the Sequence Ontology terminology for genomic variant annotation, J. Biomed. Semant., 6, 32, 10.1186/s13326-015-0030-4 · DOI
  45. Curtis, 2012, The genomic and transcriptomic architecture of 2, 000 breast tumours reveals novel subgroups, Nature, 486, 346, 10.1038/nature10983 · DOI · Paper page
  46. Danecek, 2011, The variant call format and VCFtools, Bioinformatics, 27, 2156, 10.1093/bioinformatics/btr330 · DOI · Paper page
  47. David, 2012, Protein-protein interaction sites are hot spots for disease-associated nonsynonymous SNPs, Hum. Mutat., 33, 359, 10.1002/humu.21656 · DOI · Paper page
  48. David, 2015, The contribution of missense mutations in core and rim residues of protein-protein interfaces to human disease, J. Mol. Biol., 427, 2886, 10.1016/j.jmb.2015.07.004 · DOI · Paper page
  49. de Beer, 2013, Amino acid changes in disease-associated variants differ radically from variants observed in the 1000 genomes project dataset, PLoS Comput. Biol., 9, e1003382, 10.1371/journal.pcbi.1003382 · DOI · Paper page
  50. Dehouck, 2009, Fast and accurate predictions of protein stability changes upon mutations using statistical potentials and neural networks: PoPMuSiC-2.0, Bioinformatics, 25, 2537, 10.1093/bioinformatics/btp445 · DOI · Paper page
  51. Deng, 2019, Prioritizing natural-selection signals from the deep-sequencing genomic data suggests multi-variant adaptation in Tibetan highlanders, Natl. Sci. Rev., 6, 1201, 10.1093/nsr/nwz108 · DOI
  52. Detlefsen, 2022, Learning meaningful representations of protein sequences, Nat. Commun., 13, 1914, 10.1038/s41467-022-29443-w · DOI · Paper page
  53. Diwan, 2021, Next generation protein structure predictions and genetic variant interpretation, J. Mol. Biol., 433, 167180, 10.1016/j.jmb.2021.167180 · DOI · Paper page
  54. do Nascimento, 2020, A decision tree to improve identification of pathogenic mutations in clinical practice, BMC Med. Inf. Decis. Mak., 20, 52, 10.1186/s12911-020-1060-0 · DOI
  55. Dong, 2015, Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies, Hum. Mol. Genet., 24, 2125, 10.1093/hmg/ddu733 · DOI · Paper page
  56. Dorfman, 2010, Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?, Clin. Genet., 77, 464, 10.1111/j.1399-0004.2009.01351.x · DOI · Paper page
  57. Draelos, 2022, Genesis: Gene-specific machine learning models for variants of uncertain significance found in catecholaminergic polymorphic ventricular Tachycardia and Long QT syndrome-associated genes, Circ. Arrhythm. Electrophysiol., 15, e010326, 10.1161/CIRCEP.121.010326 · DOI
  58. Eberle, 2017, A reference data set of 5.4 million phased human variants validated by genetic inheritance from sequencing a three-generation 17-member pedigree, Genome Res., 27, 157, 10.1101/gr.210500.116 · DOI · Paper page
  59. Edgar, 2004, Muscle: Multiple sequence alignment with high accuracy and high throughput, Nucleic Acids Res., 32, 1792, 10.1093/nar/gkh340 · DOI · Paper page
  60. Eilbeck, 2017, Settling the score: Variant prioritization and mendelian disease, Nat. Rev. Genet., 18, 599, 10.1038/nrg.2017.52 · DOI · Paper page
  61. Fang, 2022, Vippid: A gene-specific single nucleotide variant pathogenicity prediction tool for primary immunodeficiency diseases, Brief. Bioinform., bbac176, 10.1093/bib/bbac176 · DOI
  62. Felipe-Medina, 2020, A missense in HSF2BP causing primary ovarian insufficiency affects meiotic recombination by its novel interactor C19ORF57/BRME1, Elife, 9, e56996, 10.7554/eLife.56996 · DOI · Paper page
  63. Fokkema, 2021, The LOVD3 platform: Efficient genome-wide sharing of genetic variants, Eur. J. Hum. Genet., 29, 1796, 10.1038/s41431-021-00959-x · DOI · Paper page
  64. Fokkema, 2019, Dutch genome diagnostic laboratories accelerated and improved variant interpretation and increased accuracy by sharing data, Hum. Mutat., 40, 2230, 10.1002/humu.23896 · DOI
  65. Font-Porterias, 2021, The counteracting effects of demography on functional genomic variation: The roma paradigm, Mol. Biol. Evol., 38, 2804, 10.1093/molbev/msab070 · DOI
  66. Fortuno, 2018, Improved, ACMG-compliant, in silico prediction of pathogenicity for missense substitutions encoded by TP53 variants, Hum. Mutat., 39, 1061, 10.1002/humu.23553 · DOI
  67. Frederic, 2009, UMD-Predictor, a new prediction tool for nucleotide substitution pathogenicity -- application to four genes: FBN1, FBN2, TGFBR1, and TGFBR2, Hum. Mutat., 30, 952, 10.1002/humu.20970 · DOI
  68. Fu, 2013, Analysis of 6, 515 exomes reveals the recent origin of most human protein-coding variants, Nature, 493, 216, 10.1038/nature11690 · DOI · Paper page
  69. Ganesan, 2019, HuVarBase: A human variant database with comprehensive information at gene and protein levels, PLoS One, 14, e0210475, 10.1371/journal.pone.0210475 · DOI · Paper page
  70. Genomes Project, 2012, An integrated map of genetic variation from 1, 092 human genomes, Nature, 491, 56, 10.1038/nature11632 · DOI · Paper page
  71. Genomes Project, 2015, A global reference for human genetic variation, Nature, 526, 68, 10.1038/nature15393 · DOI · Paper page
  72. Giardine, 2014, Updates of the HbVar database of human hemoglobin variants and thalassemia mutations, Nucleic Acids Res., 42, D1063, 10.1093/nar/gkt911 · DOI · Paper page
  73. Gonzalez-Perez, 2011, Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel, Am. J. Hum. Genet., 88, 440, 10.1016/j.ajhg.2011.03.004 · DOI · Paper page
  74. Greenblatt, 2008, Locus-specific databases and recommendations to strengthen their contribution to the classification of variants in cancer susceptibility genes, Hum. Mutat., 29, 1273, 10.1002/humu.20889 · DOI
  75. Haraksingh, 2013, Impacts of variation in the human genome on gene regulation, J. Mol. Biol., 425, 3970, 10.1016/j.jmb.2013.07.015 · DOI · Paper page
  76. Hassan, A review study: Computational techniques for expecting the impact of non-synonymous single nucleotide variants in human diseases, Gene, 680, 20, 10.1016/j.gene.2018.09.028 · DOI
  77. Hassan, Evaluation of computational techniques for predicting non-synonymous single nucleotide variants pathogenicity, Genomics, 111, 869, 10.1016/j.ygeno.2018.05.013 · DOI
  78. Hebert, 2020, Burden of rare deleterious variants in WNT signaling genes among 511 myelomeningocele patients, PLoS One, 15, e0239083, 10.1371/journal.pone.0239083 · DOI
  79. Hecht, 2015, Better prediction of functional effects for sequence variants, BMC Genomics, 16, S1, 10.1186/1471-2164-16-S8-S1 · DOI · Paper page
  80. Hoie, 2022, Predicting and interpreting large-scale mutagenesis data using analyses of protein stability and conservation, Cell. Rep., 38, 110207, 10.1016/j.celrep.2021.110207 · DOI · Paper page
  81. Holtgrewe, 2020, VarFish: Comprehensive DNA variant analysis for diagnostics and research, Nucleic Acids Res., 48, W162-W169, 10.1093/nar/gkaa241 · DOI
  82. Hu, 2021, Next-generation sequencing technologies: An overview, Hum. Immunol., 82, 801, 10.1016/j.humimm.2021.02.012 · DOI · Paper page
  83. International HapMap, 2003, The international HapMap project, Nature, 426, 789, 10.1038/nature02168 · DOI · Paper page
  84. Ip, 2019, Vpot: A customizable variant prioritization ordering tool for annotated variants, Genomics Proteomics Bioinforma., 17, 540, 10.1016/j.gpb.2019.11.001 · DOI
  85. Jagadeesh, 2016, M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity, Nat. Genet., 48, 1581, 10.1038/ng.3703 · DOI · Paper page
  86. Javed, 2014, Phen-gen: Combining phenotype and genotype to analyze rare disorders, Nat. Methods, 11, 935, 10.1038/nmeth.3046 · DOI · Paper page
  87. Ji, 2016, Increased burden of deleterious variants in essential genes in autism spectrum disorder, Proc. Natl. Acad. Sci. U. S. A., 113, 15054, 10.1073/pnas.1613195113 · DOI
  88. Johnston, 2013, Databases of genomic variation and phenotypes: Existing resources and future needs, Hum. Mol. Genet., 22, R27, 10.1093/hmg/ddt384 · DOI
  89. Jones, 1979, The effect of hemoglobin F-Chesapeake (alpha 2 92 Arg. leads to Leu gamma 2) on fetal oxygen affinity and erythropoiesis, Pediatr. Res., 13, 851, 10.1203/00006450-197907000-00011 · doi:10.1203/00006450-197907000-00011
  90. Jordan, 2011, Development and validation of a computational method for assessment of missense variants in hypertrophic cardiomyopathy, Am. J. Hum. Genet., 88, 183, 10.1016/j.ajhg.2011.01.011 · DOI
  91. Ka, 2021, DNA sequencing costs: Data from the NHGRI genome sequencing Program (GSP)
  92. Kaminker, 2007, CanPredict: A computational tool for predicting cancer-associated missense mutations, Nucleic Acids Res., 35, W595, 10.1093/nar/gkm405 · DOI · Paper page
  93. Kanzi, 2020, Next generation sequencing and bioinformatics analysis of family genetic inheritance, Front. Genet., 11, 544162, 10.3389/fgene.2020.544162 · DOI
  94. Karczewski, 2020, The mutational constraint spectrum quantified from variation in 141, 456 humans, Nature, 581, 434, 10.1038/s41586-020-2308-7 · DOI · Paper page
  95. Karczewski, 2020, The mutational constraint spectrum quantified from variation in 141, 456 humans, Nature, 581, 434, 10.1038/s41586-020-2308-7 · DOI · Paper page
  96. Katsonis, 2019, CAGI5: Objective performance assessments of predictions based on the Evolutionary Action equation, Hum. Mutat., 40, 1436, 10.1002/humu.23873 · DOI
  97. Katsonis, 2022, Genome interpretation using in silico predictors of variant impact, Hum. Genet., 10.1007/s00439-022-02457-6 · DOI
  98. Keerthikumar, 2009, Rapid: Resource of asian primary immunodeficiency diseases, Nucleic Acids Res., 37, D863, 10.1093/nar/gkn682 · DOI
  99. Kim, 2015, Detection and analysis of disease-associated single nucleotide polymorphism influencing post-translational modification, BMC Med. Genomics, 8, S7, 10.1186/1755-8794-8-S2-S7 · DOI
  100. Kimura, 1979, The neutral theory of molecular evolution, Sci. Am., 241, 98, 10.1038/scientificamerican1179-98 · DOI · Paper page
  101. Kircher, 2014, A general framework for estimating the relative pathogenicity of human genetic variants, Nat. Genet., 46, 310, 10.1038/ng.2892 · DOI · Paper page
  102. Koboldt, 2020, Best practices for variant calling in clinical sequencing, Genome Med., 12, 91, 10.1186/s13073-020-00791-w · DOI · Paper page
  103. Kohler, 2021, The human phenotype ontology in 2021, Nucleic Acids Res., 49, D1207, 10.1093/nar/gkaa1043 · DOI · Paper page
  104. Krogh, 1994, Hidden Markov models in computational biology. Applications to protein modeling, J. Mol. Biol., 235, 1501, 10.1006/jmbi.1994.1104 · DOI · Paper page
  105. Kulshreshtha, 2016, Computational approaches for predicting mutant protein stability, J. Comput. Aided. Mol. Des., 30, 401, 10.1007/s10822-016-9914-3 · DOI
  106. Lai, 2020, Leap: Using machine learning to support variant classification in a clinical setting, Hum. Mutat., 41, 1079, 10.1002/humu.24011 · DOI
  107. Laimer, 2015, MAESTRO--multi agent stability prediction upon point mutations, BMC Bioinforma., 16, 116, 10.1186/s12859-015-0548-6 · DOI · Paper page
  108. Lanktree, 2018, Prevalence estimates of polycystic kidney and liver disease by population sequencing, J. Am. Soc. Nephrol., 29, 2593, 10.1681/ASN.2018050493 · DOI · Paper page
  109. Lek, 2016, Analysis of protein-coding genetic variation in 60, 706 humans, Nature, 536, 285, 10.1038/nature19057 · DOI · Paper page
  110. Leu, 2015, Genome-wide polygenic burden of rare deleterious variants in sudden unexpected death in epilepsy, EBioMedicine, 2, 1063, 10.1016/j.ebiom.2015.07.005 · DOI
  111. Li, 2009, Automated inference of molecular mechanisms of disease from amino acid substitutions, Bioinformatics, 25, 2744, 10.1093/bioinformatics/btp528 · DOI · Paper page
  112. Li, 2018, VarCards: An integrated genetic and clinical database for coding variants in the human genome, Nucleic Acids Res., 46, D1039-D1048, 10.1093/nar/gkx1039 · DOI · Paper page
  113. Li, 2018, Performance evaluation of pathogenicity-computation methods for missense variants, Nucleic Acids Res., 46, 7793, 10.1093/nar/gky678 · DOI · Paper page
  114. Li, 2017, Robust and rapid algorithms facilitate large-scale whole genome sequencing downstream analysis in an integrative framework, Nucleic Acids Res., 45, e75, 10.1093/nar/gkx019 · DOI
  115. Li, 2012, A comprehensive framework for prioritizing variants in exome sequencing studies of Mendelian diseases, Nucleic Acids Res., 40, e53, 10.1093/nar/gkr1257 · DOI · Paper page
  116. Li, 2017, InterVar: Clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines, Am. J. Hum. Genet., 100, 267, 10.1016/j.ajhg.2017.01.004 · DOI · Paper page
  117. Li, 2020, Capice: A computational method for consequence-agnostic pathogenicity interpretation of clinical exome variations, Genome Med., 12, 75, 10.1186/s13073-020-00775-w · DOI · Paper page
  118. Li, 2015, The identification of cis-regulatory elements: A review from a machine learning perspective, Biosystems., 138, 6, 10.1016/j.biosystems.2015.10.002 · DOI
  119. Liu, 2019, Doc2Hpo: A web application for efficient and accurate HPO concept curation, Nucleic Acids Res., 47, W566-W570, 10.1093/nar/gkz386 · DOI · Paper page
  120. Liu, 2017, ONGene: A literature-based database for human oncogenes, J. Genet. Genomics, 44, 119, 10.1016/j.jgg.2016.12.004 · DOI · Paper page
  121. Lo, 2021, Detecting genetic ancestry and adaptation in the Taiwanese han people, Mol. Biol. Evol., 38, 4149, 10.1093/molbev/msaa276 · DOI
  122. Ma, 2013, A novel channelopathy in pulmonary arterial hypertension, N. Engl. J. Med., 369, 351, 10.1056/NEJMoa1211097 · DOI · Paper page
  123. Maffucci, 2019, Blacklisting variants common in private cohorts but not in public databases optimizes human exome analysis, Proc. Natl. Acad. Sci. U. S. A., 116, 950, 10.1073/pnas.1808403116 · DOI
  124. Mahmood, 2017, Variant effect prediction tools assessed using independent, functional assay-based datasets: Implications for discovery and diagnostics, Hum. Genomics, 11, 10, 10.1186/s40246-017-0104-8 · DOI · Paper page
  125. Martinez, 1977, Haemoglobin J Guantanamo (alpha 2 beta 2 128 (H6) Ala replaced by Asp). A new fast unstable haemoglobin found in a Cuban family, Biochim. Biophys. Acta, 491, 1, 10.1016/0005-2795(77)90034-4 · DOI
  126. McLaren, 2016, The ensembl variant effect predictor, Genome Biol., 17, 122, 10.1186/s13059-016-0974-4 · DOI · Paper page
  127. McLaren, 2010, Deriving the consequences of genomic variants with the ensembl API and SNP effect predictor, Bioinformatics, 26, 2069, 10.1093/bioinformatics/btq330 · DOI · Paper page
  128. Melendez-Aranda, 2019, In silico analysis of missense mutations in exons 1-5 of the F9 gene that cause hemophilia B, BMC Bioinforma., 20, 363, 10.1186/s12859-019-2919-x · DOI
  129. Mi, 2021, PANTHER version 16: A revised family classification, tree-based classification tool, enhancer regions and extensive API, Nucleic Acids Res., 49, D394, 10.1093/nar/gkaa1106 · DOI · Paper page
  130. Miller, 2019, What went wrong with variant effect predictor performance for the PCM1 challenge, Hum. Mutat., 40, 1486, 10.1002/humu.23832 · DOI
  131. Moo-Penn, 1988, Hemoglobin brockton [beta 138 (H16) ala----pro]: An unstable variant near the C-terminus of the beta-subunits with normal oxygen-binding properties, Biochemistry, 27, 7614, 10.1021/bi00420a007 · DOI
  132. Morningstar-Kywi, 2021, Ligand-specific pharmacogenetic effects of nonsynonymous mutations, Pharmacogenet. Genomics, 31, 75, 10.1097/FPC.0000000000000424 · DOI
  133. Muller, 2017, VCF.Filter: Interactive prioritization of disease-linked genetic variants from sequencing data, Nucleic Acids Res., 45, W567-W572, 10.1093/nar/gkx425 · DOI
  134. Ng, 2001, Predicting deleterious amino acid substitutions, Genome Res., 11, 863, 10.1101/gr.176601 · DOI · Paper page
  135. Ng, 2003, Sift: Predicting amino acid changes that affect protein function, Nucleic Acids Res., 31, 3812, 10.1093/nar/gkg509 · DOI · Paper page
  136. Nikam, 2021, ProThermDB: Thermodynamic database for proteins and mutants revisited after 15 years, Nucleic Acids Res., 49, D420, 10.1093/nar/gkaa1035 · DOI · Paper page
  137. Niroula, 2015, PON-P2: Prediction method for fast and reliable identification of harmful variants, PLoS One, 10, e0117380, 10.1371/journal.pone.0117380 · DOI · Paper page
  138. Niroula, 2015, Classification of amino acid substitutions in Mismatch Repair proteins using PON-MMR2, Hum. Mutat., 36, 1128, 10.1002/humu.22900 · doi:10.1002/humu.22900
  139. Niroula, 2019, How good are pathogenicity predictors in detecting benign variants?, PLoS Comput. Biol., 15, e1006481, 10.1371/journal.pcbi.1006481 · DOI · Paper page
  140. Ohno, 2018, Rules and tools to predict the splicing effects of exonic and intronic mutations, WIREs RNA, 9, 10.1002/wrna.1451 · DOI
  141. Okido, 2022, DNA Data Bank of Japan (DDBJ) update report 2021, Nucleic Acids Res., 50, D102, 10.1093/nar/gkab995 · DOI
  142. Orgogozo, 2015, The differential view of genotype-phenotype relationships, Front. Genet., 6, 179, 10.3389/fgene.2015.00179 · DOI
  143. Palmer, 2022, Exome sequencing in bipolar disorder identifies AKAP11 as a risk gene shared with schizophrenia, Nat. Genet., 54, 541, 10.1038/s41588-022-01034-x · DOI · Paper page
  144. Pandurangan, 2017, Sdm: A server for predicting effects of mutations on protein stability, Nucleic Acids Res., 45, W229-W235, 10.1093/nar/gkx439 · DOI · Paper page
  145. Peng, 2019, Combining newborn metabolic and DNA analysis for second-tier testing of methylmalonic acidemia, Genet. Med., 21, 896, 10.1038/s41436-018-0272-5 · DOI
  146. Pereira, 2016, The somatic mutation profiles of 2, 433 breast cancers refines their genomic and transcriptomic landscapes, Nat. Commun., 7, 11479, 10.1038/ncomms11479 · DOI · Paper page
  147. Perez-Enciso, 2019, A guide for using deep learning for complex trait genomic prediction, Genes. (Basel), 10, E553, 10.3390/genes10070553 · DOI · Paper page
  148. Petukh, 2015, On human disease-causing amino acid variants: Statistical study of sequence and structural patterns, Hum. Mutat., 36, 524, 10.1002/humu.22770 · DOI · Paper page
  149. Pollard, 2010, Detection of nonneutral substitution rates on mammalian phylogenies, Genome Res., 20, 110, 10.1101/gr.097857.109 · DOI · Paper page
  150. Poon, 2021, In silico analysis of BRCA1 and BRCA2 missense variants and the relevance in molecular genetic testing, Sci. Rep., 11, 11114, 10.1038/s41598-021-88586-w · DOI
  151. Quang, 2015, Dann: A deep learning approach for annotating the pathogenicity of genetic variants, Bioinformatics, 31, 761, 10.1093/bioinformatics/btu703 · DOI · Paper page
  152. Quinodoz, 2022, Analysis of missense variants in the human genome reveals widespread gene-specific clustering and improves prediction of pathogenicity, Am. J. Hum. Genet., 109, 457, 10.1016/j.ajhg.2022.01.006 · DOI
  153. Reva, 2007, Determinants of protein function revealed by combinatorial entropy optimization, Genome Biol., 8, R232, 10.1186/gb-2007-8-11-r232 · DOI · Paper page
  154. Reva, 2011, Predicting the functional impact of protein mutations: Application to cancer genomics, Nucleic Acids Res., 39, e118, 10.1093/nar/gkr407 · DOI · Paper page
  155. Robinson, 2020, Interpretable clinical genomics with a likelihood ratio paradigm, Am. J. Hum. Genet., 107, 403, 10.1016/j.ajhg.2020.06.021 · DOI
  156. Rojano, 2019, Regulatory variants: From detection to predicting impact, Brief. Bioinform., 20, 1639, 10.1093/bib/bby039 · DOI
  157. Saito, 2011, Fabry-database.org: Database of the clinical phenotypes, genotypes and mutant alpha-galactosidase A structures in Fabry disease, J. Hum. Genet., 56, 467, 10.1038/jhg.2011.31 · doi:10.1038/jhg.2011.31
  158. Salgado, 2016, UMD-predictor: A high-throughput sequencing compliant system for pathogenicity prediction of any human cDNA substitution, Hum. Mutat., 37, 439, 10.1002/humu.22965 · DOI
  159. Sallah, 2020, Using an integrative machine learning approach utilising homology modelling to clinically interpret genetic variants: CACNA1F as an exemplar, Eur. J. Hum. Genet., 28, 1274, 10.1038/s41431-020-0623-y · DOI
  160. Sanavia, 2020, Limitations and challenges in protein stability prediction upon genome variations: Towards future applications in precision medicine, Comput. Struct. Biotechnol. J., 18, 1968, 10.1016/j.csbj.2020.07.011 · DOI · Paper page
  161. Sarkar, 2020, Variation benchmark datasets: Update, criteria, quality and applications
  162. Sasidharan Nair, 2013, VariBench: A benchmark database for variations, Hum. Mutat., 34, 42, 10.1002/humu.22204 · DOI · Paper page
  163. Savojardo, 2019, Are machine learning based methods suited to address complex biological problems? Lessons from CAGI-5 challenges, Hum. Mutat., 40, 1455, 10.1002/humu.23784 · DOI
  164. Sayers, 2022, GenBank., GenBank. Nucleic Acids Res., 50, D161, 10.1093/nar/gkab1135 · DOI · Paper page
  165. Schaafsma, 2015, VariSNP, a benchmark database for variations from dbSNP, Hum. Mutat., 36, 161, 10.1002/humu.22727 · DOI · Paper page
  166. Schiemann, 2016, Comparison of pathogenicity prediction tools on missense variants in RYR1 and CACNA1S associated with malignant hyperthermia, Br. J. Anaesth., 117, 124, 10.1093/bja/aew065 · DOI
  167. Schwarz, 2014, MutationTaster2: Mutation prediction for the deep-sequencing age, Nat. Methods, 11, 361, 10.1038/nmeth.2890 · DOI · Paper page
  168. Sherry, 2001, dbSNP: the NCBI database of genetic variation, Nucleic Acids Res., 29, 308, 10.1093/nar/29.1.308 · DOI · Paper page
  169. Shihab, Predicting the functional consequences of cancer-associated amino acid substitutions, Bioinformatics, 29, 1504, 10.1093/bioinformatics/btt182 · DOI · Paper page
  170. Shihab, Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models, Hum. Mutat., 34, 57, 10.1002/humu.22225 · DOI · Paper page
  171. Shihab, 2013, Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models, Hum. Mutat., 34, 57, 10.1002/humu.22225 · DOI · Paper page
  172. Shihab, 2014, Ranking non-synonymous single nucleotide polymorphisms based on disease concepts, Hum. Genomics, 8, 11, 10.1186/1479-7364-8-11 · DOI · Paper page
  173. Sifrim, 2013, eXtasy: variant prioritization by genomic data fusion, Nat. Methods, 10, 1083, 10.1038/nmeth.2656 · DOI · Paper page
  174. Sim, 2012, SIFT web server: Predicting effects of amino acid substitutions on proteins, Nucleic Acids Res., 40, W452, 10.1093/nar/gks539 · DOI · Paper page
  175. Smedley, 2015, Next-generation diagnostics and disease-gene discovery with the Exomiser, Nat. Protoc., 10, 2004, 10.1038/nprot.2015.124 · DOI · Paper page
  176. Smigielski, 2000, dbSNP: a database of single nucleotide polymorphisms, Nucleic Acids Res., 28, 352, 10.1093/nar/28.1.352 · DOI · Paper page
  177. Somody, 2017, Structural coverage of the proteome for pharmaceutical applications, Drug Discov. Today, 22, 1792, 10.1016/j.drudis.2017.08.004 · DOI · Paper page
  178. Steinhaus, 2021, MutationTaster2021, Nucleic Acids Res., 49, W446, 10.1093/nar/gkab266 · DOI · Paper page
  179. Stone, 2005, Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity, Genome Res., 15, 978, 10.1101/gr.3804205 · DOI · Paper page
  180. Sunyaev, 2000, Towards a structural basis of human non-synonymous single nucleotide polymorphisms, Trends Genet., 16, 198, 10.1016/s0168-9525(00)01988-0 · DOI · Paper page
  181. Suybeng, 2020, Comparison of pathogenicity prediction tools on somatic variants, J. Mol. Diagn., 22, 1383, 10.1016/j.jmoldx.2020.08.007 · DOI
  182. Tam, 2019, Benefits and limitations of genome-wide association studies, Nat. Rev. Genet., 20, 467, 10.1038/s41576-019-0127-1 · DOI · Paper page
  183. Terui, 2013, CoDP: Predicting the impact of unclassified genetic variants in MSH6 by the combination of different properties of the protein, J. Biomed. Sci., 20, 25, 10.1186/1423-0127-20-25 · DOI
  184. Thomas, 2003, Panther: A library of protein families and subfamilies indexed by function, Genome Res., 13, 2129, 10.1101/gr.772403 · DOI · Paper page
  185. Thomas, 2004, Coding single-nucleotide polymorphisms associated with complex vs. Mendelian disease: Evolutionary evidence for differences in molecular effects, Proc. Natl. Acad. Sci. U. S. A., 101, 15398, 10.1073/pnas.0404380101 · DOI · Paper page
  186. Thomas, 2006, Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools, Nucleic Acids Res., 34, W645, 10.1093/nar/gkl229 · DOI · Paper page
  187. Thorisson, 2009, Genotype-phenotype databases: Challenges and solutions for the post-genomic era, Nat. Rev. Genet., 10, 9, 10.1038/nrg2483 · DOI
  188. Tischkowitz, 2008, Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach, Eur J Hum Genet, 16, 820, 10.1038/ejhg.2008.13 · DOI
  189. Trisilowati,, 2012, In silico experimental modeling of cancer treatment, ISRN Oncol., 2012, 828701, 10.5402/2012/828701 · DOI
  190. Vihinen, 2021, Functional effects of protein variants, Biochimie, 180, 104, 10.1016/j.biochi.2020.10.009 · DOI
  191. Vihinen, 2013, Guidelines for reporting and using prediction tools for genetic variation analysis, Hum. Mutat., 34, 275, 10.1002/humu.22253 · DOI · Paper page
  192. Vihinen, 2012, How to evaluate performance of prediction methods? Measures and their interpretation in variation effect analysis, BMC Genomics, 13, S2, 10.1186/1471-2164-13-S4-S2 · DOI · Paper page
  193. Vihinen, 2014, Variation Ontology for annotation of variation effects and mechanisms, Genome Res., 24, 356, 10.1101/gr.157495.113 · DOI
  194. Wang, 2010, Annovar: Functional annotation of genetic variants from high-throughput sequencing data, Nucleic Acids Res., 38, e164, 10.1093/nar/gkq603 · DOI · Paper page
  195. Wei, 2018, Missing value imputation approach for mass spectrometry-based metabolomics data, Sci. Rep., 8, 663, 10.1038/s41598-017-19120-0 · DOI · Paper page
  196. Witvliet, 2016, ELASPIC web-server: Proteome-wide structure-based prediction of mutation effects on protein stability and binding affinity, Bioinformatics, 32, 1589, 10.1093/bioinformatics/btw031 · DOI
  197. Won, 2021, 3Cnet: Pathogenicity prediction of human variants using multitask learning with evolutionary constraints, Bioinformatics, 37, 4626, 10.1093/bioinformatics/btab529 · DOI
  198. Worth, 2011, SDM--a server for predicting effects of mutations on protein stability and malfunction, Nucleic Acids Res., 39, W215, 10.1093/nar/gkr363 · DOI · Paper page
  199. Xavier, 2019, TAPES: A tool for assessment and prioritisation in exome studies, PLoS Comput. Biol., 15, e1007453, 10.1371/journal.pcbi.1007453 · DOI
  200. Yazar, 2021, In silico tools and approaches for the prediction of functional and structural effects of single-nucleotide polymorphisms on proteins: An expert review., OMICS, 25, 23, 10.1089/omi.2020.0141 · DOI

200 of 210 shown

Metadata

Authors
Liu, Y., Yeung, W. S. B., Chiu, P. C. N., & Cao, D.
Venue
Frontiers in Genetics
Published
2022-09-29
Volume
13
Pages
981005-981005
ISSN
1664-8021 (ISSN-L)
OpenAlex
W4298002151
Cited by
41
References
50
FWCI
4.31
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.